Fibrates and high-dose statins to prevent coronary heart disease events.

Suppr

超能文献

作者信息

Jones P H

机构信息

Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Curr Cardiol Rep. 1999 Sep;1(3):223-4. doi: 10.1007/s11886-999-0026-8.

DOI:10.1007/s11886-999-0026-8

PMID:10980845

Abstract

摘要

相似文献

Fibrates and high-dose statins to prevent coronary heart disease events.

Curr Cardiol Rep. 1999 Sep;1(3):223-4. doi: 10.1007/s11886-999-0026-8.

The effects of fibrates on lipoprotein and hemostatic coronary risk factors.贝特类药物对脂蛋白及止血性冠心病危险因素的影响。

Atherosclerosis. 1994 Dec;111(2):161-74. doi: 10.1016/0021-9150(94)90090-6.

Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.贝特类药物在调节甘油三酯和高密度脂蛋白胆固醇代谢中的作用机制。

Drugs Today (Barc). 2006 Jan;42(1):39-64. doi: 10.1358/dot.2006.42.1.963528.

[Fibrates: mechanism of action, effect on levels of lipids and lipoproteins, risk of coronary events. Part 1. Clofibrate, gemfibrosil, besafibrate].[贝特类药物：作用机制、对脂质和脂蛋白水平的影响、冠状动脉事件风险。第1部分。氯贝丁酯、吉非贝齐、苯扎贝特]

Kardiologiia. 2004;44(2):96-103.

Normocholesterolaemic dyslipidaemia: is there a role for fibrates?正常胆固醇血症性血脂异常：贝特类药物是否有作用？

Med J Aust. 2001 Jan 15;174(2):66-7. doi: 10.5694/j.1326-5377.2001.tb143155.x.

Treatment of dyslipidaemias in patients with established vascular disease: a revival of the fibrates.已确诊血管疾病患者血脂异常的治疗：贝特类药物的复兴

Curr Med Res Opin. 2000;16(1):21-32. doi: 10.1185/0300799009117004.

Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?高密度脂蛋白（HDL）和甘油三酯水平与预防中风有关吗？

Cardiovasc Res. 2001 Nov;52(2):199-207. doi: 10.1016/s0008-6363(01)00383-2.

Hypertriglyceridemia and the fibrate trials.高甘油三酯血症与贝特类药物试验

Curr Opin Lipidol. 2000 Dec;11(6):609-14. doi: 10.1097/00041433-200012000-00007.

Drug interactions with fibric acids.

Pharmacol Ther. 1994 Aug;63(2):163-76. doi: 10.1016/0163-7258(94)90043-4.

Triglycerides and coronary heart disease: implications of recent clinical trials.甘油三酯与冠心病：近期临床试验的启示

J Cardiovasc Risk. 2000 Oct;7(5):339-45. doi: 10.1177/204748730000700507.

本文引用的文献

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.在稳定型冠状动脉疾病中，强化降脂治疗与血管成形术的比较。阿托伐他汀与血运重建治疗研究组。

N Engl J Med. 1999 Jul 8;341(2):70-6. doi: 10.1056/NEJM199907083410202.

Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis.富含甘油三酯的脂蛋白残粒与动脉粥样硬化风险

Circulation. 1999 Jun 8;99(22):2852-4. doi: 10.1161/01.cir.99.22.2852.

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.他汀类药物的抗动脉粥样硬化血栓形成特性：对减少心血管事件的影响。

JAMA. 1998 May 27;279(20):1643-50. doi: 10.1001/jama.279.20.1643.

Statin trials and goals of cholesterol-lowering therapy.他汀类药物试验与降胆固醇治疗目标

Circulation. 1998 Apr 21;97(15):1436-9. doi: 10.1161/01.cir.97.15.1436.

Molecular bases of the acute coronary syndromes.急性冠状动脉综合征的分子基础

Circulation. 1995 Jun 1;91(11):2844-50. doi: 10.1161/01.cir.91.11.2844.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验